Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis

Rebuma Belete; Zerihun Ataro; Ahmedmenewer Abdu; Merga Sheleme

doi:10.1186/s13098-021-00641-8

journal article Open Access Mar 02, 2021

Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis

Rebuma Belete

Zerihun Ataro Ahmedmenewer Abdu Merga Sheleme

Diabetology & Metabolic Syndrome Vol. 13 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s13098-021-00641-8

Abstract

AbstractBackgroundThe presence of metabolic syndrome among diabetes patients is frequent and is associated with an increased incidence of chronic complications and mortality. Despite several studies have been conducted, there is no overall estimation on the prevalence of metabolic syndrome among type 1 diabetic patients. Therefore, this study aimed to estimate the pooled prevalence of metabolic syndrome among patients with type 1 diabetes mellitus.MethodsMedline via PubMed, CINAHL, ScienceDirect, Ovid, Google Scholar, ResearchGate and African Journals Online were searched by limiting publication period from January 2005 to October 2020. Data were extracted with a standardized format prepared in Microsoft Excel and exported to Stata 16.0 for analyses. The I2statistic was used to check heterogeneity across the included studies. DerSimonian and Laird random-effects model was applied to estimate pooled prevalence and 95% confidence interval across studies. Funnel plot symmetry, Begg’s test and Egger’s regression test were used to determine the presence of publication bias. Subgroup and sensitivity analysis as well as meta-regression were conducted to explore the potential sources of heterogeneity. The study protocol is registered on PROSPERO with reference number: CRD42020213435.ResultsIn this meta-analysis, a total of 27 studies with 45,811 study participants were included. The pooled prevalence of metabolic syndrome was 23.7% with substantial heterogeneity (I2 = 98.2%; P < 0.001). Geographical-based subgroup analysis revealed that the highest prevalence was observed in Australia (27.3%). As per meta-analysis of 17 studies, the pooled prevalence of metabolic syndrome in female type 1 diabetes patients (25.9%) was slightly higher than male T1DM patients (22.5%).ConclusionNearly a quarter of the type 1 diabetes mellitus patients were affected by metabolic syndrome. Therefore, more attention should be paid to the prevention and control of the epidemic and for the reduction of the morbidity and mortality associated with metabolic syndrome among type 1 diabetes mellitus patients.

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80. 10.1111/j.1464-5491.2006.01858.x

[2]

Mccracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20. 10.1016/j.clindermatol.2017.09.004

[3]

Cankurtaran M, Halil M, Balam B, Dagli N. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch Gerontol Geriatr. 2006;42:35–45. 10.1016/j.archger.2005.05.004

[4]

Chillarón JJ, Le-Roux JA, Benaiges D, Pedro-Botet J. Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism. 2014;63(2):181–7. 10.1016/j.metabol.2013.10.002

[5]

Li X, Cao C, Tang X, Yan X, Zhou H, Liu J, Ji L, Yang X, Zhou Z. Prevalence of metabolic syndrome and its determinants in newly-diagnosed adult-onset diabetes in China: a multi-center, cross-sectional survey. Front Endocrinol. 2019;10:661. 10.3389/fendo.2019.00661

[6]

Sarafidis PA, Nilsson PM. The metabolic syndrome : a glance at its history. J Hypertens. 2006;24:621–6. 10.1097/01.hjh.0000217840.26971.b6

[7]

Chillarón JJ, Flores-le-roux JA, Goday A, Benaiges D, Carrera MJ. Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors. Rev Esp Cardiol. 2010;63(4):423–9. 10.1016/s0300-8932(10)70063-4

[8]

Soliman HM, Mosaad YO, Ibrahim A. The prevalence and the clinical profile of metabolic syndrome in children and adolescents with type 1 diabetes. Diabetes Metab Syndr Clin Res Rev. 2019;13:1723–6. 10.1016/j.dsx.2019.03.036

[9]

Consultation WHO. Definition, diagnosis, and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.

[10]

Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3. 10.1046/j.1464-5491.1999.00059.x

[11]

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection. Circulation. 2002;106:3143–421. 10.1161/circ.106.25.3143

[12]

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52. 10.1161/circulationaha.105.169404

[13]

IDF Epidemiology Task Force Consensus Group. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. [Accessed 25 September 2020]. Available from: https://www.idf.org/component/attachments/attachments.html?id=705&task=download.

[14]

Harmonizing the Metabolic Syndrome

K.G.M.M. Alberti, Robert H. Eckel, Scott M. Grundy et al.

Circulation 2009 10.1161/circulationaha.109.192644

[15]

Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17(101):1–9.

[16]

do Vale Moreira NC, Hussain A, Bhowmik B, Mdala I, Siddiquee T, Fernandes VO, Jay RM, Meyer HE. Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1217–24. 10.1016/j.dsx.2020.05.043

[17]

Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord. 2013;11(2):71–80. 10.1089/met.2012.0122

[18]

Tan MC, Ng OC, Wong TW, Joseph A, Chan Y, AR Hejar. Prevalence of metabolic syndrome in type 2 diabetic patients: a comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions. Health. 2013;(2013).

[19]

Łuczyński W, Szypowska A, Głowińska-Olszewska B, Bossowski A. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy. Eur J Pediatr. 2011;170:891–8. 10.1007/s00431-010-1372-7

[20]

Ahola AJ, Harjutsalo V, Thorn LM, Freese R, Forsblom C, Mäkimattila S, et al. The association between macronutrient intake and the metabolic syndrome and its components in type 1 diabetes. Br J Nutr. 2017;117(3):450–6. 10.1017/s0007114517000198

[21]

Gingras V, Leroux C, Fortin A, Legault L, Rabasa-lhoret R. Predictors of cardiovascular risk among patients with type 1 diabetes: a critical analysis of the metabolic syndrome and its components. Diabetes Metab. 2017;43(3):217–22. 10.1016/j.diabet.2016.10.007

[22]

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols ( PRISMA-P ) 2015 statement. Syst Rev. 2015;4(1):1–9. 10.1186/2046-4053-4-1

[23]

Wells GA, Shea B, O’Connell DA, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 19 Oct 2020.

[24]

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. 10.1002/sim.1186

[25]

Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34. 10.1136/bmj.315.7109.629

[26]

Sterne JAC, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119–29. 10.1016/s0895-4356(00)00242-0

[27]

Blaslov K, Bulum T, Zibar K, Duvnjak L. Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1. J Diabetes. 2015;7(3):340–6. 10.1111/1753-0407.12194

[28]

Merger SR, Kerner W, Stadler M, Zeyfang A, Jehle P, Müller-Korbsch M, et al. Prevalence and comorbidities of double diabetes. Diabetes Res Clin Pract. 2016;119:48–56. 10.1016/j.diabres.2016.06.003

[29]

Barros BSV, Santos DC, Pizarro MH, Gomes LG, Brito M. Type 1 diabetes and non-alcoholic fatty liver disease: when should we be concerned? A nationwide study in Brazil. Nutrients. 2017;9:878. 10.3390/nu9080878

[30]

Davis TME, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2007;78(3):412–7. 10.1016/j.diabres.2007.06.007

[31]

Huo L, Ji L, Deng W, Shaw JE, Zhang P, Zhao F, et al. Age distribution and metabolic disorders in people with type 1 diabetes in Beijing and Shantou, China: a cross-sectional study. Diabet Med. 2018;35(6):721–8. 10.1111/dme.13616

[32]

Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type I diabetes: “double diabetes” in the diabetes control and complications trial. Diabetes Care. 2007;30(3):707–12. 10.2337/dc06-1982

[33]

Köken ÖY, Kara C. Prevalence of obesity and metabolic syndrome in children with type 1 diabetes: a comparative assessment based on criteria established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program. J Clin Res Pediatr Endocrinol. 2020;12(1):55–62. 10.4274/jcrpe.galenos.2019.2019.0048

[34]

Nádas J, Putz Z, Nyi JF, Gaali Z, Gyimesi A, Neuwirth G, et al. Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2009;117:107–12. 10.1055/s-0028-1082068

[35]

Pambianco G, Costacou T, Trevor JO. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care. 2007;30(5):1248–54. 10.2337/dc06-2053

[36]

Riccardo B, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care. 2006;29:2701–7. 10.2337/dc06-0942

[37]

Saki F. Prevalence of metabolic syndrome in children with type 1 diabetes in South of Iran. J Compr Ped. 2016;7(3):e37703. 10.17795/compreped-37703

[38]

Santos CE, Schrank Y, Kupfer R. Análise crítica dos critérios da OMS, IDF e NCEP para síndrome metabólica em pacientes portadores de diabetes melito tipo 1. Arq Bras Endocrinol Metab. 2009;53(9):1096–102. 10.1590/s0004-27302009000900006

[39]

Szadkowska A, Pietrzak I, Szlawska J, Kozera A, Gadzicka A, Młynarski W. Abdominal obesity, metabolic syndrome in type 1 diabetic children and adolescents. Pediatr Endocrinol Diabetes Metab. 2009;15(4):233–9.

[40]

Valerio G, Iafusco D, Zucchini S, Maffeis C. Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2012;97(1):99–104. 10.1016/j.diabres.2012.01.022

[41]

Ghosh S, Collier A, Hair M, Malik I, Elhadd T. Metabolic syndrome in type 1 diabetes. Int J Diabetes Mellit. 2010;2:38–42. 10.1016/j.ijdm.2009.10.005

[42]

Lee AS, Twigg SM, Flack JR. Metabolic syndrome in type 1 diabetes and its association with diabetes complications. Diabet Med. 2020;38:e14376. 10.1111/dme.14376

[43]

McGill M, Molyneaux L, Twigg SM, Yue DK. The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J Diabetes Complications. 2008;22(1):18–23. 10.1016/j.jdiacomp.2006.10.005

[44]

Billow A, Anjana RM, Ngai M, Amutha A, Pradeepa R, Jebarani S, et al. Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India. J Diabetes Complicat. 2015;29(5):659–64. 10.1016/j.jdiacomp.2015.03.014

[45]

Ferreira-hermosillo A, Ramírez-rentería C, Mendoza-zubieta V, Molina-ayala MA. Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus. Diabetol Metab Syndr. 2014;6(1):32. 10.1186/1758-5996-6-32

[46]

Reinehr T, De SG, Toschke M, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child. 2007;92:1067–72. 10.1136/adc.2006.104588

[47]

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. 10.1186/1741-7015-9-48

[48]

Ferreira-Hermosillo A, Molina-Ayala M, Ramírez-Rentería C, Vargas G, Gonzalez B, Isibasi A, Archundia-Riveros I, Mendoza V. Inflammatory cytokine profile associated with metabolic syndrome in adult patients with type 1 diabetes. J Diabetes Res. 2015;2015:972073. 10.1155/2015/972073

[49]

Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, et al. Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care. 2009;32:160–4. 10.2337/dc08-1419

[50]

Lee AS, Twigg SM, Flack JR. Metabolic syndrome in type 1 diabetes and its association with diabetes complications. Diabet Med. 2020. https://doi.org/10.1111/dme.14376. 10.1111/dme.14376

Showing 50 of 53 references

Cited By

104

Peculiarities of cesarean section in a pregnant woman with morbid obesity (case report)

O.V. Golyanovskiy, O.Yu. Kachur · 2025

Reproductive health of woman

Recent Advances in the Therapeutic Potential of Carotenoids in Preventing and Managing Metabolic Disorders

Ana E. Ortega-Regules, Juan Alonso Martínez-Thomas · 2024

Plants

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

Constantine E. Kosmas, Shanna Rodriguez Polanco · 2023

Diagnostics

Metrics

104

Citations

53

References

Details

Published: Mar 02, 2021
Vol/Issue: 13(1)
License: View

Authors

Cite This Article

Rebuma Belete, Zerihun Ataro, Ahmedmenewer Abdu, et al. (2021). Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome, 13(1). https://doi.org/10.1186/s13098-021-00641-8

Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis

You May Also Like